Biocatalytic methylation in drug discovery

Authors

• Diana Amariei, Astra Zeneca, SwedenFollow
• Pascal Schneider, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
• Mikhail Kabeshov, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
• Felix Faber, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
• Lucy Harwood, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
• Agnes Ingvarsson, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
• Martin Hayes, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
• Christof Jäger, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Conference Dates

October 19-24, 2025

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Diana Amariei, Pascal Schneider, Mikhail Kabeshov, Felix Faber, Lucy Harwood, Agnes Ingvarsson, Martin Hayes, and Christof Jäger, "Biocatalytic methylation in drug discovery" in "Enzyme Engineering XXVIII", John Woodley, DTU; Ditte Hededam-Welner, DTU Eds, ECI Symposium Series, (2025). https://dc.engconfintl.org/enzyme_xxviii/88